Literature DB >> 28097656

Palliation and breast cancer.

Cheng-Har Yip1.   

Abstract

Metastatic breast cancer is an incurable disease. With improvement in systemic therapy, survival has improved over the past few years. Removing the primary tumor has shown improved survival in retrospective studies, but this may be due to selection bias. The first reported randomized controlled trial (RCT) from India showed no difference in survival with surgery. However another RCT from Turkey showed that a select group of patient with bone-only metastases have a survival benefit.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  metastatic breast cancer; surgery; survival

Mesh:

Year:  2017        PMID: 28097656     DOI: 10.1002/jso.24560

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Factors Associated with Time to Progression and Overall Survival in Patients with De Novo Metastatic Breast Cancer: A Colombian Cohort.

Authors:  Sandra Esperanza Díaz-Casas; Ximena Briceño-Morales; Leidy Juliana Puerto-Horta; Carlos Lehmann-Mosquera; Martha Cecilia Orozco-Ospino; Luis Hernán Guzmán-AbiSaab; Javier Ángel-Aristizábal; Mauricio García-Mora; Carlos Alfonso Duarte-Torres; Iván Fernando Mariño-Lozano; Clara Briceño-Morales; Ricardo Sánchez-Pedraza
Journal:  Oncologist       Date:  2022-03-04       Impact factor: 5.837

Review 2.  Cooperation between Angiogenesis, Vasculogenesis, Chemotaxis, and Coagulation in Breast Cancer Metastases Development: Pathophysiological Point of View.

Authors:  Elżbieta Zarychta; Barbara Ruszkowska-Ciastek
Journal:  Biomedicines       Date:  2022-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.